Status:
COMPLETED
The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Lead Sponsor:
University of Milano Bicocca
Collaborating Sponsors:
Azienda Ospedaliera San Gerardo di Monza
Conditions:
Psychosis;Schizophrenic
Personality Disorders
Eligibility:
All Genders
18-65 years
Brief Summary
The outbreak of the SARS-CoV-2 pandemic may be considered a traumatic phenomenon. In a sample of subjects suffering from different psychiatric disorders, psychopathological status and Post-Traumatic ...
Detailed Description
SARS-CoV-2 epidemic is a worldwide phenomenon which generated fear, anxiety, depression and PTSD symptoms, as a consequence of the high number of deaths and the restricted measures adopted by the Ital...
Eligibility Criteria
Inclusion
- understanding of the Italian language
- ability to understand and sign written informed consent
Exclusion
- severe mental retardation
- pregnancy or post-partum period
- severe or chronic medical condition
- health workers
Key Trial Info
Start Date :
November 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04694482
Start Date
November 12 2020
End Date
January 31 2021
Last Update
September 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Milan Bicocca - Ospedale San Gerardo
Monza, MB, Italy, 20900